Hyeri Kim

Dr. Hyeri Kim


Research Focus & Metrics

Representative Publications

View All Publications
20 February 2023 in Current Oncology
Verified
Journal Article
Open access
PDF file
HKHyeri Kim
Hyeri Kim
SKSeung Ho Kim
Seung Ho Kim
KNKyung Han Nam
Kyung Han Nam
Background: To evaluate the association between perfusion parameters derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) with prognostic factors in primary rectal cancer patients. Methods: A sample of 51 patients with pathologically proven rectal adenocarcinoma through surgery were retrospectively enrolled. All the patients underwent preoperative DCE-MRI including 3D-spoiled gradient echo. Two radiologists determined the tumor border after radiologic–pathologic correlation and drew regions of interest. The perfusion parameters, including the volume transfer constant (Ktrans), were calculated under the extended Toft model. The prognostic factors included TN stage, circumferential resection margin, extramural venous invasion, Kirsten-ras mutation, tumor size, carcinoembryonic antigen, and tumor differentiation. The association was assessed via correlation or t-test. For significant prognostic factors, receiver operating characteristic (ROC) curve analyses were performed to estimate the diagnostic predictive values. Results: Ktrans only showed a significant difference according to tumor differentiation, between the well-differentiated (n = 6) and moderately differentiated (n = 45) groups (0.127 ± 0.032, 0.084 ± 0.036, p = 0.036). The AUC was 0.838 (95% CI, 0.702–0.929), and the estimated accuracy, sensitivity, and specificity were 87%, 90%, and 60%, respectively. Conclusions: Ktrans showed a significant difference based on tumor differentiation, which may be conducive to prediction of prognosis in primary rectal cancer.

1 April 2023 in Ultrasonography
Verified
Journal Article
Open access
PDF file
YLYun-Jung Lim
Yun-Jung Lim
SSSu-Mi Shin
Su-Mi Shin
HKHyeri Kim
Hyeri Kim
MCMi Lim Chung
Mi Lim Chung
SHSeok Hahn
Seok Hahn
YCYeon Jin Cho
Yeon Jin Cho
Purpose: Subpial hemorrhage (SPH) is a subtype of intracranial hemorrhage characterized by damage to the adjacent brain parenchyma. The aim of this study was to describe the sonographic features of SPH in neonates.Methods: The cranial ultrasound (US) findings of neonates with SPH confirmed by brain magnetic resonance imaging (MRI) were analyzed retrospectively. Initial and follow-up US and MRI scans were reviewed by two pediatric radiologists who were blinded to both clinical history and outcomes. The US features were compared with the MRI findings.Results: Sixteen patients were included (median gestational age, 38 weeks; range, 26 to 40 weeks; 69% term). SPH was detected most often in the temporal lobe (63%), and multiple SPHs were found in seven of 16 neonates, based on MRI. Acute SPH with an underlying venous infarct (UVI) was detected on US in 15 of 16 patients: small or large fan-shaped hyperechoic lesions (n=7 and 4, respectively) and gyriform hyperechoic lesions (n=4). The sonographic yin-yang sign was observed in three of the four large fan-shaped SPH cases. The accompanying findings on US were intraventricular hemorrhage (four out of six MRI-confirmed cases), and concurrent periventricular venous infarcts (five out of nine MRI-confirmed cases). In five patients, subpial cysts were observed on follow-up US or MRI (n=4 and n=4, respectively).Conclusion: Acute SPH with UVI can appear as a peripheral fan-shaped or gyriform hyperechoic lesion on cranial US. SPH can be detected and suspected based on the US features of SPH with the accompanying findings.

Verified
Journal Article
Open access
PDF file
GLGeon Lee
Geon Lee
SKSeung Ho Kim
Seung Ho Kim
MKMingyu Kim
Mingyu Kim
DKDajung Kim
Dajung Kim
HKHyeri Kim
Hyeri Kim
Background/Objectives: From the viewpoint of personalized medicine, it is important to properly select patients with a complete response (CR) after neoadjuvant chemoradiotherapy (nCRT) because they are candidates for “watch-and-wait” management in locally advanced rectal cancer (LARC). The aims of this study were to evaluate the added value of diffusion-weighted imaging (DWI) b2000 to high-resolution T2-weighted images (HR-T2WI) and to compare the diagnostic performance of DWI b2000 and b1000 for assessing a CR in patients with LARC after nCRT. Methods: This retrospective study included 55 patients (male: 40, female: 15; mean age: 60.1) who underwent pre- and post-nCRT 3T MRI, including DWIb1000 and DWIb2000. Two blinded radiologists independently assessed the likelihood of a CR using a five-point scale across three image sets: T2-weighted images (T2WI), T2WI + DWIb1000, and T2WI + DWIb2000. T2WI were provided because DWI is not used as a standalone sequence in clinical practice when evaluating the therapeutic response to nCRT. A crossover review of DWIb1000 and DWIb2000 with a four-week interval was used to minimize recall bias. The reference standard of a CR was histopathologic examination or clinical remission in cases of watch-and-wait management. For each reader, diagnostic performance was compared across three image sets using pairwise comparisons of the receiver operating characteristic (ROC) curves. Results: The study population comprised 19 patients with a CR and 36 patients with residual tumor. For both readers, adding DWIb2000 significantly enhanced diagnostic performance compared to T2WI alone (AUC for reader 1: 0.918, 0.806, p = 0.0288; AUC for reader 2: 0.868, 0.768, p = 0.0414, respectively), likewise, DWIb1000 (for reader 1: 0.955, p = 0.0015; for reader 2: 0.863, p = 0.0162). However, no significant difference in diagnostic performance was found between DWIb1000 and DWIb2000 for each reader (for reader 1: p = 0.0931; for reader 2: p = 0.8936). Conclusions: Adding DWIb2000 to T2WI improved diagnostic performance for identifying a CR after nCRT compared to T2WI alone. No statistical difference was detected between DWIb1000 and DWIb2000.